Aptamer-based proteomics of serum and plasma in acquired aplastic anemia
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Experimental Hematology
- Vol. 68, 38-50
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance ToolPLOS ONE, 2012
- Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia developmentLeukemia, 2011
- Differences between Human Plasma and Serum Metabolite ProfilesPLOS ONE, 2011
- Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromesHaematologica, 2010
- Aptamer-Based Multiplexed Proteomic Technology for Biomarker DiscoveryPLOS ONE, 2010
- Platelet is a major contributor to circulating levels of Dickkopf‐1: clinical implications in patients with multiple myelomaBritish Journal of Haematology, 2009
- Wnt Signaling in the Niche Enforces Hematopoietic Stem Cell Quiescence and Is Necessary to Preserve Self-Renewal In VivoCell Stem Cell, 2008
- Function and biological roles of the Dickkopf family of Wnt modulatorsOncogene, 2006
- Current concepts in the pathophysiology and treatment of aplastic anemiaBlood, 2006
- Differentiation of hematopoietic progenitor cells towards the myeloid and B‐lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokinesEuropean Journal of Haematology, 2006